Han, Xiaonan
Ji, Chengfan
Tian, Siyu
Wang, Fengze https://orcid.org/0000-0002-8347-8004
Cao, Guo-Ping
Li, Ding
Duan, Xiaomin
Tong, Zhou https://orcid.org/0000-0002-9867-2838
Qi, Jianxun https://orcid.org/0000-0002-9358-4732
Wang, Qihui https://orcid.org/0000-0003-3768-0401
Huang, Qingrui https://orcid.org/0009-0007-2076-3805
Zhan, Bing-Dong https://orcid.org/0000-0003-3916-1306
Gao, George Fu https://orcid.org/0000-0002-3869-615X
Yan, Jinghua https://orcid.org/0009-0003-3238-255X
Funding for this research was provided by:
National Natural Science Foundation of China (92369202)
National Natural Science Foundation of China (92369202)
Article History
Received: 5 September 2024
Accepted: 22 September 2025
First Online: 3 November 2025
Competing interests
: J.Y., X.H., C.J., S.T., F.W., Z.T., and G.F.G. are listed as inventors on a patent application for the use of C34 and C37 antibodies. All other authors declare no competing interests.